By determining the composition in muropeptides of the murein of a number of strains of Escherichia coli, purffied from cells at various states of growth, the sacculus was found to be considerably modified when cells stop active growth. Murein from resting cells becomes hypercross-linked and richer in covalently bound lipoprotein, whereas the mean length of the glycan chains is considerably reduced. The alteration of the sacculus occurs progressively during the transitions from active growth to stationary phase and vice versa.
During the last few years a considerable amount of evidence has accumulated supporting the idea that the bacterial sacculus is subjected to a fairly dynamic metabolism by postinsertional modification of its structure and chemical composition (6-9, 13, 16) . In exponentially growing Escherichia coli, the peptidoglycan newly inserted into the growing sacculus acquires its characteristic final composition by a maturation process in which it becomes further cross-linked and richer in covalently bound lipoprotein (6) . The maturation of murein in E. coli occurs on a time scale similar to that of the cell cycle; therefore, the mean composition of the murein remains constant as long as the cells continue growing exponentially.
Whereas aging of the peptidoglycan during the cell cycle has considerable experimental support, there is little information on possible alterations in the structure of the sacculus during transitions between states of growth. The recent demonstration in E. coli and other microorganisms of dramatic changes in the levels of some penicillin-binding proteins during the transitions from active growth into stationary phase (and vice versa [2] [3] [4] ) provided a further reason for us to investigate the problem in detail.
Our task has been made considerably easier by the timely development by Schwarz et al. of a method that applies the powerful techniques of high-pressure liquid chromatography (H.P.L.C.) to the analysis of the peptidoglycan (7, 11) . The method revealed the presence of at least 31 different muropeptides in the peptidoglycan of E. coli. Some had a rather surprising structure (dimeric muropeptides cross-linked via a diaminopimelyl-diaminopimelic acid direct bridge [crosslinked trimers]) which may play important structural roles in the murein sacculus.
Our results indicate that, in E. coli, the murein undergoes considerable changes during the transition from the exponential phase of growth into stationary phase, and vice versa.
MATERIALS AND METHODS
Organisms and growth conditions. The following strains of E. coli were used in this study: E. coli W7 dapA lysA (10) , KN126 K12 F-ilv trpA9(Am) tyr(Am) sup-126(Ts) (17), and MC6 K12 F-proA leuA thr thyA thi dra drm (5) . Bacteria * Corresponding author.
were cultivated at 37°C with shaking in L broth (14) supplemented with 10 mg of meso-diaminopimelic acid and per liter 50 mg of thymine per liter.
Radiochemicals. meso-3,4,5,[3H]diaminopimelic acid (35 Ci/mmol; 2.5 mCi/ml) was purchased from Commisariat a l'Energie Atomique, Service des Molecules Marquees, Gifsur-Yvette, France.
Purification of peptidoglycan. Peptidoglycan was prepared as described by Holtje et al. (12) . A volume of culture was mixed to a dilution of 1:1 with 8% boiling sodium dodecyl sulfate (SDS) and incubated for 50 to 60 min in a boiling-water bath. After cooling to 40°C, SDS-insoluble material was recovered by centrifugation (100,000 x g; 45 min), suspended in warm water (35 to 40°C), and centrifuged again under the same conditions. The last step was repeated twice to get rid of SDS. The last pellet was resuspended in 10 mM Tris-10 mM NaCl (pH 7.2) and digested with a-amilase (100 ,ug/ml; 1 h at 37°C) and with pronase E (100 p.g/ml; 1 h at 60°C (7). To facilitate nomenclature, the following abbreviations were used: gly 4 (5), glycine residue at position 4 (or 5) in the peptide side chain of the muropeptide; lys.arg, lysine-arginine dipeptide from a molecule of covalently bound lipoprotein at the diaminopimelic acid residue of the peptide side chain of the muropeptide; anhydro, (1-6)-anhydromuramyl residue in the disaccharide moiety of the muropeptide; (dap-dap), muropeptide cross-linked by a diaminopimelyl-diaminopimelic acid peptide bridge. penta, pentapeptide side chain; tetra, tetrapeptide side chain; apd tri, tripeptide side chain. Peaks: 1, disaccharide-tri; 2, disaccharide-tetra-gly 4; 3, disaccharide-tetra; 4, disaccharide-penta-gly 5; 5, disaccharide-dipeptide; 6, disaccharide-penta; 7, disaccharide-tri-lys-arg; 8, bisdisaccharide-tetra-tri-gly 4; 9, bisdisaccharide-tri-tri-(dapdap); 10, bisdisaccharide-tetra-tri; 11, bisdisaccharide-tetra-tri-(dap-dap) plus bisdisaccharide-tetra-tetra-gly 4; 12, disaccharide-trianhydro; 13, bisdisaccharide-tetra-penta-gly 5; 14, bisdisaccharide-tetra-tetra; 15, bisdisaccharide-tetra-penta; 16, bisdisaccharide-tri-tri-(dapdap)-lys-arg; 17, disaccharide-tetra-anhydro; 18, trisdisaccharide-tetra-tetra-tri-(dap-dap); 19, trisdisaccharide-tetra-tetra-tetra; 20, bisdisaccharide-tetra-tri-(dap-dap)-lys-arg; 21, bisdisaccharide-tri-tri-(dap-dap)-anhydro; 22, trisdisaccharide-tetra-tri-tri-(dap-dap)-lys-arg; 23, bisdisaccharide-tetra-tri-anhydro; 24, bisdisaccharide-tetra-tri-(dap-dap)-anhydro; 25, bisdisaccharide-tetra-tetra-anhydro; 26, trisdisaccharidetetra-tetra-tri-anhydro; 27, trisdisaccharide-tetra-tetra-tri-(dap-dap)-anhydro; 28, Tris-disaccharide-tetra-tetra-tetra-anhydro; 29, bisdisaccharide-tri-tri-(dap-dap)-lys-arg-anhydro; 30, bisdisaccharide-tetra-tri-(dap-dap)-lys-arg-anhydro; and 31, trisdisaccharide-tetra-tetra-tri-(dap-dap)-lys-arg-anhydro.
The radioactivity of each fraction was measured by liquid scintillation, with Bray fluid as the scintillator (1) .
Muropeptides have been grouped into the following families for this study: monomers (all of the disaccharide peptides [peak numbers [1] [2] [3] [4] [5] [6] [7] 12 , and 17; Fig. 1]) ; dimers (all of the bisdisaccharide peptides [peak numbers 8-11, 13-16, 20 , 21, 23-25, 29, and 30; Fig. 1]) ; trimers (all of the cross-linked tridisaccharide peptides [peak numbers 18, 19, 22, 26-28, and 31; Fig. 1]) ; diaminopimelyl-diaminopimelic acid muropeptides (all cross-linked muropeptides with a diaminopimelyl-diaminopimelic acid bridge in their molecule [peak numbers 9, 11, 16, 18, 20, 24, 27, 29-31; Fig. 1 
RESULTS
Composition of the peptidoglycan purified from cultures in exponential phase and 6 h after entering stationary phase. A 400-ml culture of E. coli W7 growing exponentially at 37°C for 6 generations was divided into two subcultures at an absorbance at 550 nm of 1. One was immediately used to isolate peptidoglycan; the second was incubated for 9 h more, until it had been in stationary phase for 6 h before peptidoglycan was isolated from it. Both samples were processed and analyzed by HPLC as indicated above. The relative amount of each muropeptide was determined by integration of the corresponding peaks on the UV absorption profiles of the chromatograms (Fig. 1) .
Murein from stationary-phase cells ( The rate of incorporation of meso-[3H]diaminopimelic acid into macromolecular murein in the various samples was estimated by taking portions from each sample after boiling in SDS. The samples were filtered through Millipore HAWP filters, washed with boiling water, dried, and measured by liquid scintillation (see Table 2 ).
With meso-[3H]diaminopimelic acid pulse-labeling, it was possible to compare, at any given time, the mean composition of total murein obtained by UV monitoring of the chromatograms with that of newly made murein calculated by the distribution of radioactivity among the various muropeptides. Although this method allowed a parallel estimation of the relative changes in new and total murein, data from UV absorbance and radioactivity should not be strictly compared on a quantitative basis, because the molar extinction coefficients for each muropeptide had not yet been determined accurately. The evolution of the various groups of muropeptides in total and newly made murein are shown in Tables 3 and 4 , respectively.
The results indicate that the alterations of the peptidoglycan during cessation of growth, as well as during its resumption, do not occur abruptly but gradually over considerable periods of time.
DISCUSSION
As shown by the data presented here, the transition of the cells from exponential growth into stationary phase is paralleled by a concomitant modification of the murein which becomes more cross-linked and richer in covalently bound lipoprotein as well as compounds of shorter glycan chains. The tnodification of the peptidoglycan occurs gradually, beginning as soon as the growth rate declines, although murein does not attain its final stable composition until the cells have been in stationary phase for ca. 12 h.
Hypercross-linking of murein in resting cells involves a remarkable rise in the level of trimeric cross-linked muropeptides (more than 50%) as well as in the amount of muropeptides that are cross-linked by direct diaminopimelyl-diaminopimelic acid peptide bridges. In fact, the increase in the mole fraction of the latter kind of muropeptides, from 5.8 to 10.6% (see Table 3 for a comparison of exponential cells and Fig. 1 Fig. 1 and Tables 2 and 3. VOL. 161, 1985 on July 7, 2017 by guest http://jb.asm.org/ Downloaded from 242 PISABARRO, DE PEDRO, AND VAZQUEZ values found showed that the composition of murein after one doubling in cell mass was already similar to that of exponentially growing cells (see Table 3 ), with, again, the significant exception of the anhydromuropeptides. Their kinetics of change corresponds fairly closely with that expected from the dilution model. The results discussed above suggest a working hypothesis in which the modifications taking place in murein during the transitions in the state of cell growth are coupled to the murein biosynthetic process itself. Affecting these changes are murein-modifying systems which are particularly active when resting cells commence growth.
Rather unexpected was the fact that even after a long period in stationary phase, cells continue synthesis of peptidoglycan. Furthermore, the murein synthesized at that time was very different from that synthesized at any period during the transitions in the state of growth of the cells, since it was particularly rich in diaminopimelyl-diaminopimelic acid bridges, muropeptides with anhydromuramyl residues, and cross-linked trimers. Interestingly, preliminary results from a study, now under way, on the nature of the incorporation of meso-[3H]diaminopimelic acid into resting cells suggest that it might be due to a turnover process rather than to cumulative synthesis of the peptidoglycan.
